GlassScriptPhysician profile
Dianna Liu
NPI 1477830511
$3,884.41
in general payments reported to CMS, 2019-2025
18 companies · $739 in 2025
The $739 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2021: $248 · 2022: $625 · 2023: $1,079 · 2024: $874 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,691.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,557.48 | 2021-2025 | Hydrus Microstent, Lensx, Clareon |
| Abbvie INC. | $954.83 | 2022-2025 | |
| Glaukos Corporation | $339.98 | 2019-2023 | Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Tarsus Pharmaceuticals, INC. | $133.14 | 2024-2025 | Xdemvy |
| Coherus Oncology, INC. | $125.00 | 2023 | |
| Allergan, INC. | $115.20 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $87.39 | 2019 | |
| Sun Pharmaceutical Industries INC. | $79.64 | 2019-2024 | |
| Harrow Eye, LLC | $77.18 | 2023-2025 | Vevye, Iheezo |
| Johnson & Johnson Surgical Vision, INC. | $66.87 | 2025 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Thea Pharma INC. | $58.68 | 2022-2024 | Iyuzeh |
| New World Medical,INC. | $56.02 | 2019-2025 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Biogen, INC. | $54.00 | 2022-2024 | Byooviz |
| Novartis Pharmaceuticals Corporation | $51.58 | 2019 | |
| Astellas Pharma US INC | $49.78 | 2023-2025 | Izervay |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $37.69 | 2019 | |
| Bausch & Lomb Americas INC. | $23.81 | 2024 | Envista Mx60 Iol |
| Sight Sciences, INC. | $16.14 | 2025 | Omni Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dianna Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.